PDR for Herbal Medicines

(Barré) #1
824 /WITCH HAZEL

Dorsch W, Neues iiber antientziindliche Drogen. Z Phytother
14: 26. 1993.
Erdelmeier CAJ et al., Antiviral and antiphlogistic activities of
Hamamelis virginiana bark. Planta Med 62: 241-245. 1996.
Friedrich H, Kriiger N, Planta Med 25: 138. 1974.
Haberland C, Kolodziej H, Novel galloylhamamelose from
Hamamelis virginiana. Planta Med 59: A608. 1993.
Hansel R, Keller K, Rimpler H, Schneider G (Ed). Hagers
Handbuch der Pharmazeutischen Praxis, 5. Aufl., Bde 4 - 6
(Drogen), Springer Verlag Berlin, Heidelberg, New York. 1992-
1994.
Hartisch C et al.. Dual inhibitory activities of tannins from
Hamamelis virginiana and related polyphenols on 5-
lipoxygenase and Lyso-PAF: Acetyl-CoA-Acetyltransferase.
Planta Med 63: 106-110. 1997.
Hartisch C et al., Proanthocyanidin pattern in Hamamelis
virginiana. Planta Med 62 (Abstracts of the 44th Ann Congress
ofGA) 119. 1996.
Hartisch C et al.. Study on the localisation and composition ot
the volatile fraction of Hamamelis virginiana. Planta Med 62
(Abstracts of the 44th Ann Congress of GA) 133.1996.
Knoch HG, Hamorrhoiden I. Grades. Wirksamkeit einer Salbe
auf pflanzlicher Basis. Munch Med Wschr 31/32: 481-484.
1991.
Korting HC, Schafer-Korting M. Hart H et al.. Anti-
inflammatory activity of hamamelis distillate applied topically to
the skin. Influence of vehicle and dose. Eur J Clin Pharmacol
44: 315-318: 1993.
Laux P, Oschmann R, Die ZaubernuP - Hamamelis virginiana
L. Z Phytother 14: 155-166. 1993.
Leung AY, Encyclopedia of Common Natural Ingredients Used
in Food Drugs and Cosmetics, John Wiley & Sons Inc. New
York 1980.
Madaus G, Lehrbuch der Biologischen Arzneimittel, Bde 1-3,
Nachdruck, Georg Olms Verlag Hildesheim 1979.
Mennet-von Eiff M, Meier B, Phytotherapie in der
Dermatologie. Z Phytother 16 (1995), 201-210
Messerschmidt W, Arch Pharm 300: 550. 1967.
Messerschmidt W, Arzneim Forsch 18: 1618. 1968.
Schulz R, Hansel R, Rationale Phytotherapie. Springer Verlag
Heidelberg 1996.
Sorkin B, Hametum-Salbe, eine kortikoidfreie
antiinflammatorische Salbe. Phys Med Rehab 21: 53-57. 1980.
Steinegger E, Hansel R, Pharmakognosie, 5. Aufl., Springer
Verlag Heidelberg 1992.

Teuscher E, Biogene Arzneimittel. 5. Aufl., Wiss.
Verlagsgesellschaft Stuttgart 1997.


Wagner H, Wiesenauer M, Phytotherapie. Phytopharmaka und
pflanzliche Homoopathika. Fischer-Verlag, Stuttgart, Jena, New
York 1995.


PDR FOR HERBAL MEDICINES

Wichtl M (Ed), Teedrogen, 4. Aufl., Wiss. Verlagsges. Stuttgart
1997.

Wood Anemone


(


Anemone nemorosa


DESCRIPTION
Medicinal Parts: The medicinal parts are the fresh plant
gathered shortly before the flowers open and the dried aerial
parts of the plant.

Flower and Fruit: The white flowers are solitary and located
at the end of a long stem. The stem is erect when in flower,
white to reddish-violet, and has a diameter of 1.5 to 4 cm.
The usually 6 (but possibly 5 to 9) bracts are oblong-ovate,
entire-margined and glabrous. The flowers have numerous
yellow stamens. The 10 to 20 carpels are oblong with a short
curved beak. They are downy and 4 to 5 mm long. The fruit
is a drooping compound with a roughly haired fruitlet.

Leaves, Stem and Root: Anemone nemorosa is a perennial
plant, 6 to 30 cm high with a horizontally creeping, yellow to
dark brown, roundish rhizome. The stems are usually
solitary, erect, glabrous or sparsely pubescent. There is 4
usually a long-stemmed basal leaf. The leaf is tri-pinnate and
pinnatifid-serrate. The first row of pinna are stemmed and
have horizontal pinna sections, each with 1 pinna of the
second level. There are cauline rosettes of 3 leaf-like bracts,
which have a 2-cm long petiole. The bracts do not generally
have axillary buds, and are palmate and pinnatifid-serrate.

Habitat: The plant is spread almost all over Europe as far as
the Volga region except in the Mediterranean and northern
Lapland.

Production: Wood Anemone is the aerial part of Anemone
nemorosa, collected shortly before the flowers open.

Other Names: Pasque Flower, Crowfoot, Wind Flower,
Smell Fox

ACTIONS AND PHARMACOLOGY
COMPOUNDS
Protoanemonine-forming agents (yielding approximately
300 meg protoanemonine per gram of fresh weight): "
presumably, the glycoside ranunculin, which changes enzy-
matically when the plant is cut into small pieces (and
probably also when it is dried) into the pungent, volatile
protoanemonine that quickly dimerizes to anemonine; when
dried, the plant is not capable of protoanemonine formation

EFFECTS
No information is available.
Free download pdf